The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection
Open accessAbstract
Phase II metabolic enzymes are a battery of critical proteins that detoxify xenobiotics by increasing their hydrophilicity and enhancing their disposal. These enzymes have long been studied for their preventative and protective effects against mutagens and carcinogens and for their regulation via the Keap1 (Kelch-like ECH associated protein 1) / Nrf2 (Nuclear factor erythroid 2 related factor 2) / ARE (antioxidant response elements) pathway. Recently, a series of studies have reported the altered expression of phase II genes in postmortem tissue of patients with various neurological diseases. These observations hint at a role for phase II enzymes in the evolution of such conditions. Furthermore, promising findings reveal that overexpression of phase II genes, either by genetic or chemical approaches, confers neuroprotection in vitro and in vivo. Therefore, there is a need to summarize the current literature on phase II genes in the central nervous system (CNS). This should help guide future studies on phase II genes as therapeutic targets in neurological diseases. In this review, we first briefly introduce the concept of phase I, II and III enzymes, with a special focus on phase II enzymes. We then discuss their expression regulation, their inducers and executors. Following this background, we expand our discussion to the neuroprotective effects of phase II enzymes and the potential application of Nrf2 inducers to the treatment of neurological diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–215 of 215
Sequence of the reaction of heme catabolism catalyzed by the microsomal heme oxygenase system
Yoshida, T., & Kikuchi, G. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80481-3 · Cited by 41
The Expression of NF-E2-Related Factor 2 in the Rat Brain After Traumatic Brain Injury
Yan, W. X., Wang, H., Feng, X., Ding, Y., Jin, W., & Tang, K. (2009) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e318180f5c7 · Cited by 41
Zhang, L., Huang, S., Chen, Y., Wang, Z., Li, E., & Xu, Y. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00595.x · Cited by 40
Jin, W., Wang, H., Hu, Z.-G., Yan, W. X., Chen, G., & Yin, H.-X. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.08.003 · Cited by 39
Nouhi, F., Tusi, S. K., Abdi, A., & Khodagholi, F. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0417-2 · Cited by 39
Caprioli, J., Munemasa, Y., Kwong, J. M. K., & Piri, N. (2009) · PubMed · Cited by 38
4-Hydroxybenzyl Alcohol Ameliorates Cerebral Injury in Rats by Antioxidant Action
Yu, S., Zhao, J., Lei, S., Lin, X., Wang, L.-L., & Zhao, Y. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0335-8 · Cited by 36
Yu, X. Y., Egner, P. A., Wakabayashi, J., Wakabayashi, N., Yamamoto, M. P., & Kensler, T. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604620200 · Cited by 35
Tolédano, M. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.005 · Cited by 33
Modulation of Transcription Factor Nrf2 in an In Vitro Model of Traumatic Brain Injury
Hatic, H., Kane, M. J., Saykally, J. N., & Citron, B. A. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1806 · Cited by 32
Chen, Y., Yu, M., Jones, D. P., Greenamyre, J. T., & Cai, J. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.05.006 · Cited by 31
Advances in Experimental Subarachnoid Hemorrhage
Sozen, T., Tsuchiyama, R., Hasegawa, Y., Suzuki, H., Jadhav, V. R., Nishizawa, S., & Zhang, J. H. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0353-1_3 · Cited by 29
Leautaud, V., & Demple, B. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-116 · Cited by 22
Takagi, Y., Kikuta, K., Moriwaki, T., Aoki, T., Nozaki, K., Hashimoto, N., & Miyamoto, S. (2011) · Surgical Neurology International · doi:10.4103/2152-7806.80356 · Cited by 17
PGD2 and PGE2 regulate gene expression of Prx 6 in primary macrophages via Nrf2
Erttmann, S. F., Bast, A., Seidel, J., Breitbach, K., Walther, R., & Steinmetz, I. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.022 · Cited by 13
Cited by
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Melatonin: an ancient molecule that makes oxygen metabolically tolerable
Manchester, L. C., Coto‐Montes, A., Boga, J. A., Andersen, L. P. H., Zhou, Z., Galano, A., Vriend, J., Tan, D., & Reiter, R. J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12267 · Cited by 945
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
“Nrf2 status has been linked to many kinds of neurodegenerative disorders, such as Parkinson disease, multiple sclerosis, Huntington disease, Alzheimer disease, and amyotrophic lateral sclerosis (reviewed in [461, 462]).”
The Roles of NRF2 in Modulating Cellular Iron Homeostasis
Kerins, M. J., & Ooi, A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7176 · Cited by 738
Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Metadata
- Authors
- Zhang, M., An, C., Gao, Y., Leak, R. K., Chen, J., & Zhang, F.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 100
- Pages
- 30-47
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W1977334935
- Cited by
- 617
- References
- 215
- FWCI
- 12.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.